| MGLJX | SWASX | MGLJX / SWASX | |
| Total Expense Ratio | 1.94 | 0.72 | 269% |
| Annual Report Gross Expense Ratio | 1.95 | 0.72 | 271% |
| Fund Existence | 11 years | 18 years | - |
| Gain YTD | 1.948 | 10.664 | 18% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.21B | 295M | 748% |
| Annual Yield % from dividends | 1.54 | 3.17 | 49% |
| Returns for 1 year | -3.44 | 6.78 | -51% |
| Returns for 3 years | 1.28 | 21.60 | 6% |
| Returns for 5 years | -2.32 | 15.63 | -15% |
| Returns for 10 years | 14.21 | 39.26 | 36% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GMICX | 22.40 | N/A | N/A |
| GMO International Equity II | |||
| IGFSX | 10.83 | -0.06 | -0.55% |
| VY® Morgan Stanley Global Franchise S2 | |||
| MOSSX | 10.14 | -0.06 | -0.59% |
| MassMutual Overseas R5 | |||
| MGICX | 38.52 | -0.23 | -0.59% |
| MFS International Intrinsic Value C | |||
| GEMAX | 27.86 | -0.29 | -1.03% |
| Goldman Sachs Emerging Markets Eq A | |||